https://www.indianpharmapost.com/novo-nordisks-wegovy-pill-approved-in-us-as-first-oral-glp-1-for-weight-management-186482025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/take-solutions-plans-ai-driven-healthcare-platform-186612025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/cupid-reduces-promoter-pledged-stake-to-20-186602025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-inks-out-licensing-agreement-with-ajanta-to-market-semaglutide-in-26-countries-186592025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-biologics-expands-fkb-deal-to-secure-global-rights-for-adalimumab-biosimilar-186582025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-pharmaceuticals-usa-launches-epinephrine-injection-usp-multiple-dose-vial-186572025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-nod-to-myqorzo-for-obstructive-hypertrophic-cardiomyopathy-186562025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/zambon-biotech-launches-european-phase-3b-trial-for-innovative-parkinsons-drug-186552025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-go-ahead-to-roches-one-minute-follicular-lymphoma-therapy-186542025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/latify-phase-iii-trial-of-ceralasertib-fails-to-improve-survival-in-advanced-lung-cancer-186532025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/srm-global-hospitals-performs-tamil-nadus-first-tactiflex-radiofrequency-ablation-to-save-80-yr-old-patient-186522025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-grants-breakthrough-therapy-designation-to-enhertu-for-high-risk-early-breast-cancer-186512025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/china-approves-first-in-class-tgct-drug-marking-global-first-for-pimicotinib-186502025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayer-wins-japan-nod-for-finerenone-in-broad-heart-failure-population-186492025-12-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-partners-with-bioeq-for-us-commercialisation-rights-for-nufymco-186622025-12-23T00:00:00+05:30always0.9